#403 A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
- Results statistically different unless stated.
- Two newer, higher-quality Most females received oral metronidazole 400-500mg twice daily for 7 days:
- Open-label RCT (164 couples, 87% previous bacterial vaginosis, monogamous relationship ~14 months). 1 Partners given oral metronidazole 400mg and clindamycin 2% cream twice daily for 7 days, or no treatment.
- Recurrence at 12 weeks: 35% versus 63% (control), Number Needed To Treat=4
- Mean time to recurrence: 74 days versus 55 days (control).
- Adverse events, males:
- Oral: Nausea (14%), headache (12%), metallic taste (7%).
- Topical: Penile redness (4%) and irritation (7%).
- Control arm not reported.
- Stopped early for benefit (may overestimate benefit).
- Double-blind RCT (214 females with ≥2 infections in past year, 14-18% had ≥2 partners in previous 3 months).² Partners given oral metronidazole or placebo for 7 days. At 16 weeks:
- Treatment failure: No difference.
- Adverse events: No difference.
- Stopped early for futility.
- Older systematic review, 7 RCT (1026 participants), partners treated with oral antibiotics alone: no effect.3 Limitations include some non-standard treatments (example: oral metronidazole 2g single dose).
- Clindamycin cream applied to glans penis, upper shaft and under foreskin (if uncircumcised).1
- Guidelines recommend:4,5
- In females: Metronidazole 500mg orally twice daily or clindamycin 2% vaginal cream daily for 7 days; or metronidazole 0.75% vaginal gel daily for 5 days.
- Partner treatment not currently recommended.
- Oral and vaginal regimens are similarly effective; oral metronidazole has more gastrointestinal side effects.6,7
- Cost (7 days):8
- Oral: Metronidazole 500mg $28.
- Vaginal: Clindamycin 2% cream $65; metronidazole 0.75% gel $44.







